Omicron Biochemicals, Inc. develops new and improved methods to introduce stable isotopes, primarily 13C, 2H, 15N and 18O, into biologically-important compounds. We specialize in the synthesis of labeled carbohydrates, nucleosides, and their derivatives, but will undertake the synthesis of other classes of compounds on a custom basis. Our particular strengths lie in the preparation of site-specifically labeled compounds, but we are also capable of producing uniformly labeled products.
The approaches used in synthesis include chemical, chemi-enzymic, enzymic and biological methods. We also collaborate with other laboratories as needed to develop new products or distribute our products.
We take pride in providing quality stable isotopes in support of a wide range of scientific research programs worldwide. Our research activities frequently result in publication in peer-reviewed scientific journals, either independently or in conjunction with other research groups. We are a flexible research and development company, with both activities receiving equal weight and attention.
Company Details
- Employees
- 7
- Founded
- -
- Address
- 115 S Hill St, South Bend,indiana 46617,united States
- Phone
- +1-574-287-6910
- om****@****bio.com
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- omicronbio.com
- HQ
- South Bend, Indiana
Omicron Biochemicals, Inc. Questions
Omicron Biochemicals, Inc.'s helpline number is +1-574-287-6910
Omicron Biochemicals, Inc.'s website is omicronbio.com
Omicron Biochemicals, Inc.'s LinkedIn profile is https://www.linkedin.com/company/omicron-biochemicals-inc
Omicron Biochemicals, Inc. has
7 employees.
View email and phone details for 7
employees at Omicron Biochemicals, Inc..
Omicron Biochemicals, Inc.'s industry is
Biotechnology Research
Omicron Biochemicals, Inc.'s top competitors are
Fusion Pharmaceuticals,
Applied Molecular Therapies,
Amicus Therapeutics,
Nucleus Radiopharma,
Radiomedix, Inc.,
Glycobac, Llc,
Actinium Pharmaceuticals, Inc.,
Canadian Medical Isotope Ecosystem,
Cyclotek Pty Ltd,
Convergent Therapeutics, Inc..
Omicron Biochemicals, Inc.'s support email address is omicron@omicronbio.com
Omicron Biochemicals, Inc.'s categories are Biotechnology Research
Omicron Biochemicals, Inc.'s founding year is 1982
